The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
Open accessAbstract
Graft versus host disease (GVHD), mediated by donor T cells, is a significant source of morbidity and mortality following allogeneic stem cell transplantation. Mesenchymal stem cells (MSC) can successfully treat ongoing graft versus host disease, presumably due to their ability to suppress donor T cell proliferation. Little is known about the potential of MSC to prevent GVHD. Here we show that bone marrow‐isolated MSC can suppress the development of GVHD if given after donor T cell recognition of antigen. IFN‐γ was required to initiate MSC efficacy. Recipients of IFN‐γ–/– T cells did not respond to MSC treatment and succumbed to GVHD. MSC, pre‐treated with IFN‐γ, became immediately active and could suppress GVHD more efficiently than a fivefold‐greater number of MSC that were not activated. When given at the time of bone marrow transplantation, activated MSC could prevent GVHD mortality (100% survival, p=0.006). MSC activation was dependent on the magnitude of IFN‐γ exposure, with increased IFN‐γ exposure leading to increased MSC suppression of GVHD. Activated MSC present a new strategy for preventing GVHD using fewer MSC. See accompanying commentary: http://dx.doi.org/10.1002/eji.200838433
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724
Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., et al. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00769-x · Cited by 2,295
Self-citationHeterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.
Friedenstein, A. J., Kv, P., KUROLESOVA, A. I., & Frolova, G. P. (1968) · PubMed · Cited by 1,921
Phinney, D. G., & Prockop, D. J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0637 · Cited by 1,908
HETEROTOPIC TRANSPLANTS OF BONE MARROW
FRIEDENSTEIN, A. J., PETRAKOVA, K. V., KUROLESOVA, A. I., & FROLOVA, G. P. (1968) · Transplantation · doi:10.1097/00007890-196803000-00009 · Cited by 1,699
Meisel, R., Zibert, A., Laryea, M., Göbel, U., Däubener, W., & Dilloo, D. (2004) · Blood · doi:10.1182/blood-2003-11-3909 · Cited by 1,646
Kopen, G. C., Prockop, D. J., & Phinney, D. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10711 · Cited by 1,636
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., & Dazzi, F. (2003) · Blood · doi:10.1182/blood-2002-07-2104 · Cited by 1,598
Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., & Guinan, E. C. (2003) · Transplantation · doi:10.1097/01.tp.0000045055.63901.a9 · Cited by 1,500
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.-U., Dlugosz, A., Szakos, A., Hassan, Z., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000214462.63943.14 · Cited by 1,142
Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., & Rachmilewitz, J. (2005) · Blood · doi:10.1182/blood-2004-07-2921 · Cited by 1,034
Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., & Ferrara, J. L. M. (1997) · Blood · doi:10.1182/blood.v90.8.3204 · Cited by 832
Kernan, N. A., Bartsch, G., Ash, R. C., Beatty, P. G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J. A., Henslee-Downey, J., McCullough, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303043280901 · Cited by 825
Lazarus, H. M., Koc, O. N., Devine, S. M., Curtin, P., Maziarz, R. T., Holland, H. K., Shpall, E. J., McCarthy, P., Atkinson, K., Cooper, B. W., et al. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.02.001 · Cited by 803
Ryan, J. M., Barry, F., Murphy, J. M., & Mahon, B. P. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03422.x · Cited by 596
Antoine, C., Müller, S., Cant, A., Cavazzana-Calvo, M., Veys, P., Vossen, J., Fasth, A., Heilmann, C., Wulffraat, N., Seger, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12513-5 · Cited by 579
Immunomodulatory effects of fetal and adult mesenchymal stem cells
Le Blanc, K. (2003) · Cytotherapy · doi:10.1080/14653240310003611 · Cited by 514
Reisner, Y., Kapoor, N., Kirkpatrick, D., Pollack, M., Cunningham-Rundles, S., Dupont, B., Hodes, M., Good, R., & O'Reilly, R. (1983) · Blood · doi:10.1182/blood.v61.2.341.341 · Cited by 503
Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection
Baddoo, M., Hill, K., Wilkinson, R., Gaupp, D., Hughes, C., Kopen, G. C., & Phinney, D. G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10594 · Cited by 494
Zhang, W., Ge, W., Li, C., You, S., Liao, L., Han, Q., Deng, W., & Zhao, R. C. H. (2004) · Stem Cells and Development · doi:10.1089/154732804323099190 · Cited by 492
Potian, J. A., Aviv, H., Ponzio, N. M., Harrison, J. S., & Rameshwar, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3426 · Cited by 432
Spitzer, T. R., Delmonico, F., Tolkoff-Rubin, N., McAfee, S., Sackstein, R., Saidman, S., Colby, C., Sykes, M., Sachs, D. H., & Cosimi, A. B. (1999) · Transplantation · doi:10.1097/00007890-199908270-00006 · Cited by 419
IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells
English, K., Barry, F. P., Field-Corbett, C. P., & Mahon, B. P. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.04.001 · Cited by 415
Sudres, M., Norol, F., Trenado, A., Grégoire, S., Charlotte, F., Levacher, B., Lataillade, J.-J., Bourin, P., Holy, X., Vernant, J.-P., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7761 · Cited by 413
Xun, C., Thompson, J., Jennings, C., Brown, S., & Widmer, M. (1994) · Blood · doi:10.1182/blood.v83.8.2360.2360 · Cited by 360
Chabannes, D., Hill, M., Merieau, E., Rossignol, J., Brion, R., Soulillou, J. P., Anegon, I., & Cuturi, M. C. (2007) · Blood · doi:10.1182/blood-2007-02-075481 · Cited by 343
Sato, K., Yamashita, N., Yamashita, N., Baba, M., & Matsuyama, T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00055-4 · Cited by 313
Baud, O., Goulet, O., Canioni, D., Le Deist, F., Radford, I., Rieu, D., Dupuis-Girod, S., Cerf-Bensussan, N., Cavazzana-Calvo, M., Brousse, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442304 · Cited by 263
MARROW TRANSPLANTATION FOR THALASSAEMIA FOLLOWING BUSULPHAN AND CYCLOPHOSPHAMIDE
Lucarelli, G. T. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91784-2 · Cited by 258
Wagner, J. E., THOMPSON, J. S., Carter, S. L., & Kernan, N. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66996-6 · Cited by 245
Immunobiology of acute graft-versus-host disease
Reddy, P., & Ferrara, J. L. M. (2003) · Blood Reviews · doi:10.1016/s0268-960x(03)00009-2 · Cited by 242
Wang, L., Li, Y., Chen, X., Chen, J., Gautam, S. C., Xu, Y., & Chopp, M. (2002) · Hematology · doi:10.1080/10245330290028588 · Cited by 242
NASEF, A., CHAPEL, A., MAZURIER, C., BOUCHET, S., LOPEZ, M., MATHIEU, N., SENSEBÉ, L., ZHANG, Y., GORIN, N.-C., THIERRY, D., et al. (2006) · Gene Expression · doi:10.3727/000000006780666957 · Cited by 227
André-Schmutz, I., Le Deist, F., Hacein-Bey-Abina, S., Vitetta, E., Schindler, J., Chedeville, G., Vilmer, E., Fischer, A., & Cavazzana-Calvo, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09413-8 · Cited by 219
Immunobiology of acute graft-versus-host disease.
Renkonen, R. (1987) · PubMed · Cited by 212
Tisato, V, Naresh, K., Girdlestone, J., Navarrete, C., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404847 · Cited by 169
Prevention of Transfusion-Associated Graft-Versus-Host Disease by Photochemical Treatment
Grass, J. A., Wafa, T., Reames, A., et al. (1999) · Blood · doi:10.1182/blood.v93.9.3140 · Cited by 151
New approaches for preventing and treating chronic graft-versus-host disease
Lee, S. J. (2005) · Blood · doi:10.1182/blood-2004-10-4023 · Cited by 139
Recent advances in graft‐versus‐host disease (GVHD) prevention
Blazar, B. R., Korngold, R., & Daniel, A. R. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00976.x · Cited by 132
Management of acute graft‐versus‐host disease
Bacigalupo, A. P. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06533.x · Cited by 128
Min, C.-K., Kim, B.-G., Park, G., Cho, B., & Oh, I.-H. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705644 · Cited by 117
Croitoru‐Lamoury, J., Lamoury, F. M. J., Zaunders, J., Veas, L. A., & Brew, B. J. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.0037 · Cited by 115
Friedrich, W., Vetter, U. K., Heymer, B., Reisner, Y., Goldmann, S. F., Fliedner, T. M., Peter, H. H., & Kleihauer, E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91277-7 · Cited by 102
Chung, N. G., Jeong, D. C., Park, S.-J., Choi, B. O., Cho, B., Kim, H. K., Chun, C. S., & Hanb, D. C. W. (2004) · International Journal of Hematology · doi:10.1532/ijh97.a30409 · Cited by 100
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease
van Besien, K., Bartholomew, A. M., Stock, W., Peace, D. J., Devine, S. M., Sher, D., Sosman, J. A., Chen, Y.-H., Koshy, M., & Hoffman, R. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702518 · Cited by 97
Self-citationRelationships between B‐lineage lymphocytes and stromal cells in long‐term bone marrow cultures
Witte, P. L., Robinson, M., Henley, A., Low, M. G., Stiers, D. L., Perkins, S., Fleischman, R. A., & Kincade, P. W. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171014 · Cited by 88
Michálek, J., Collins, R. H., Hill, B. J., Brenchley, J. M., & Douek, D. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12917-0 · Cited by 79
Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions
Blazar, B. R., Lees, C. J., Martin, P. J., Noelle, R. J., Kwon, B. S., Murphy, W. J., & Taylor, P. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4901 · Cited by 73
Gur‐Wahnon, D., Borovsky, Z., Beyth, S., Liebergall, M., & Rachmilewitz, J. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.11.001 · Cited by 67
Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.
Ferrara, J. L. M., & Yanik, G. A. (2005) · PubMed · Cited by 59
Boulad, F., Gillio, A. P., Small, T. N., George, D., Prasad, V. K., Torok-Castanza, J., Regan, A. D., Collins, N., Auerbach, A. D., Kernan, N. A., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02443.x · Cited by 51
Szebeni, J., Wang, M.-G., Pearson, D. A., Szot, G. L., & Sykes, M. (1994) · PubMed · Cited by 49
Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts
Moadsiri, A., Polchert, D., Genrich, K., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.04.003 · Cited by 14
Self-citation
Cited by
Hass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-12 · Cited by 1,748
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0023-5 · Cited by 1,223
Mesenchymal stem cells and immunomodulation: current status and future prospects
Gao, F., Chiu, S. M., Motan, D. A. L., Zhang, Z., Chen, L., Ji, H.-L., Tse, H.-F., Fu, Q.-L., & Lian, Q. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.327 · Cited by 1,121
Multipotent mesenchymal stromal cells and the innate immune system
Le Blanc, K., & Mougiakakos, D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3209 · Cited by 1,018
Metadata
- Authors
- Polchert, D., Sobinsky, J., Douglas, G., Kidd, M., Moadsiri, A., Reina, E., Genrich, K., Mehrotra, S., Setty, S., Smith, B., & Bartholomew, A.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2008-05-20
- Volume
- 38
- Issue
- 6
- Pages
- 1745-1755
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2045080708
- Cited by
- 581
- References
- 59
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.